非他类药物治疗降低低密度脂蛋白胆固醇并改善心血管结果
Abhayjit Singh1, Leslie S Cho2
1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
新的非他类药物为降低低密度脂蛋白 (LDL) 胆固醇在动脉硬性心血管疾病 (ASCVD) 中提供了有效的选择. 本综述指导临床医生与他类药物一起或代替其使用.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 脂质代谢 脂质代谢是什么
背景情况:
- 动脉样硬化心血管疾病 (ASCVD) 仍然是主要的死亡原因,其中高低密度脂蛋白 (LDL) 胆固醇是主要的驱动因素.
- 类药物是已知的治疗方法,但有些患者需要额外或替代的降脂策略.
结论:
- 非他类药物疗法在治疗脂质不良症和降低ASCVD风险方面取得了重要进展.
- 了解它们的证据基础和处方细微差别对于最佳的患者护理至关重要.
- 一种系统的方法可以帮助确定适当启动非他类降脂治疗.
更多相关视频
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cardiovascular Drugs: Classification based on Therapeutic Indications
